PTC Therapeutics (NASDAQ: NASDAQ: PTCT) agrees to $1B Novartis collaboration On Monday, PTC Therapeutics, Inc. (NASDAQ: NASDAQ: PTCT) saw its shares surge by 20% following the announcement of a landmark deal with Novartis (SIX: NOVN) Pharmaceuticals Corporation....